-
Welcome to 2024 Chinese Congress of Holistic Integrative Oncology (2024 CCHIO) & 4th International Congress of the Asian Oncology Society (AOS2024)
On behalf of the organizing committee of the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), we are very pleased to invite you to attend the 2024 CCHIO & 4th International Congress of the Asian Oncology Society (AOS2024) . This esteemed event will be held from November 14-16, 2024, in the historic and culturally rich…
-
CGCA New Chairman Dr. Lin Chen: Moving Forward, Amplifying China’s Voice on the Global Stage丨2024 CACA Integrated Gastric Cancer Conference
On October 18-19, 2024, the CACA Integrated Gastric Cancer Conference concluded successfully in Wuhan, gathering global authorities in gastric cancer to discuss the latest advancements, pioneering developments, and standardized protocols for gastric cancer treatment. During the event, the Chinese Anti-Cancer Association Gastric Cancer Professional Committee (CGCA) completed its transition, electing Dr. Lin Chen from Peking…
-
ESMO 2024丨Dr. Tao Sun: New Breakthroughs in First-Line Treatment of Advanced TNBC with Anlotinib, Penpulimab, and Nab-Paclitaxel
The 2024 European Society for Medical Oncology (ESMO) Annual Meeting is taking place from September 13-17 in Barcelona, Spain. Dr. Tao Sun from Liaoning Cancer Hospital is leading a prospective phase II study, which will be presented as a poster at the conference (Poster Abstract No. 387P). This study explores the efficacy and safety of…
-
Dr. Ying Han: Early Diagnosis and Intervention Strategies for Refractory Primary Biliary Cholangitis
Diagnosis and Treatment of PBC PBC is a chronic autoimmune intrahepatic cholestatic disease that predominantly affects middle-aged and older women, characterized by progressive intrahepatic bile duct injury and elevated anti-mitochondrial…
-
Dr. Yong Song: Balancing Risks and Benefits of Radiotherapy and Immunotherapy for Optimal Clinical Outcomes
Recently, the “Expert Consensus on Radiotherapy Combined with Immunotherapy for Unresectable Lung Cancer (2024 Edition)” was published, co-authored by Academician Jinming Yu of Shandong Cancer Hospital, Professor Ying Cheng of Jilin Cancer Hospital, and Professor Liangan Chen of the Chinese People’s Liberation Army General Hospital. This publication marks a new level of scientific standardization in…
-
Leaders Assemble for the IASLC 2025 World Conference on Lung Cancer: A Focus on Global Collaboration and Innovation
Four international experts will jointly chair the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC), scheduled to take place in Barcelona from September 6 to 9, 2025. Here is an introduction to the incoming co-chairs who will guide the planning of WCLC 2025 and serve as ambassadors…
-
ESMO 2024丨Dr. Dingwei Ye’s Team Showcases Chinese Expertise and Innovation in Urologic Oncology on the International Stage
The 2024 European Society for Medical Oncology (ESMO) Congress took place from September 13 to 17 in Barcelona, Spain. As an annual highlight in the oncology field, ESMO attracts thousands of leading oncologists from around the world, providing a rich platform for global academic exchange. This year, multiple studies from Dr. Dingwei Ye’s team at…
-
SGBCC China Tour丨Dr. Yongmei Yin: Promoting Exchange, Building Consensus, Showcasing the International Power of Chinese Female Experts
On October 19-20, 2024, the first stop of the “St. Gallen Breast Cancer Conference (SGBCC) China Tour” was held in Nanjing. This series of events, organized by the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Beijing CSCO Clinical Oncology Research Foundation, the Beijing Kexin Medical Development Foundation, and the…
Connecting Medical Expertise through Media